ATE367438T1 - Verfahren zur steigerung der expression von menschlichen tnf-rezeptor - Google Patents

Verfahren zur steigerung der expression von menschlichen tnf-rezeptor

Info

Publication number
ATE367438T1
ATE367438T1 AT02777356T AT02777356T ATE367438T1 AT E367438 T1 ATE367438 T1 AT E367438T1 AT 02777356 T AT02777356 T AT 02777356T AT 02777356 T AT02777356 T AT 02777356T AT E367438 T1 ATE367438 T1 AT E367438T1
Authority
AT
Austria
Prior art keywords
amino acid
proline
tnf receptor
receptor expression
human tnf
Prior art date
Application number
AT02777356T
Other languages
English (en)
Inventor
William Brondyk
Xuliang Jiang
Rene Schweickhardt
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE367438T1 publication Critical patent/ATE367438T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT02777356T 2001-11-30 2002-11-21 Verfahren zur steigerung der expression von menschlichen tnf-rezeptor ATE367438T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
ATE367438T1 true ATE367438T1 (de) 2007-08-15

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777356T ATE367438T1 (de) 2001-11-30 2002-11-21 Verfahren zur steigerung der expression von menschlichen tnf-rezeptor

Country Status (12)

Country Link
US (2) US7258997B2 (de)
EP (1) EP1448772B1 (de)
JP (1) JP2005535281A (de)
AT (1) ATE367438T1 (de)
AU (1) AU2002338947B2 (de)
CA (1) CA2466298A1 (de)
DE (1) DE60221273D1 (de)
DK (1) DK1448772T3 (de)
ES (1) ES2290337T3 (de)
IL (1) IL162133A0 (de)
PT (1) PT1448772E (de)
WO (1) WO2003046160A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
EP1697414A2 (de) * 2003-12-23 2006-09-06 Applied Research Systems ARS Holding N.V. Verfahren zur herstellung von den tumornekrosefaktor bindenden proteinen
US8722348B2 (en) 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
PL2705143T3 (pl) 2011-05-02 2021-07-19 Wayne State University Technologia indukowanych białkiem komórek pluripotencjalnych, jej zastosowania
EP3060237B1 (de) 2013-10-25 2021-08-18 Wayne State University Modifiziertes reprogrammierungsprotein zur verwendung in der behandlung von krebs
CN114729353A (zh) * 2019-06-21 2022-07-08 科纳勒生物公司 经工程化的肿瘤选择性蛋白的表达

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393438B1 (de) * 1989-04-21 2005-02-16 Amgen Inc. TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
WO1993010755A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
WO2002094864A2 (en) * 2001-05-25 2002-11-28 Genset S.A. Human cdnas and proteins and uses thereof
EP1448772B1 (de) * 2001-11-30 2007-07-18 Applied Research Systems ARS Holding N.V. Verfahren zur steigerung der expression von menschlichen tnf-rezeptor

Also Published As

Publication number Publication date
IL162133A0 (en) 2005-11-20
PT1448772E (pt) 2007-10-02
US20080014635A1 (en) 2008-01-17
WO2003046160A2 (en) 2003-06-05
EP1448772A2 (de) 2004-08-25
US7258997B2 (en) 2007-08-21
WO2003046160A3 (en) 2003-07-31
AU2002338947A1 (en) 2003-06-10
DK1448772T3 (da) 2007-11-19
JP2005535281A (ja) 2005-11-24
US20050074840A1 (en) 2005-04-07
ES2290337T3 (es) 2008-02-16
EP1448772B1 (de) 2007-07-18
AU2002338947B2 (en) 2007-09-13
CA2466298A1 (en) 2003-06-05
DE60221273D1 (de) 2007-08-30

Similar Documents

Publication Publication Date Title
EA199900939A1 (ru) Остеопротегерин-связывающие белки и рецепторы
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
DE502005006284D1 (de) Keratin-bindende polypeptide
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
EA199900355A1 (ru) Теломераза обратная тринскриптаза
ME00185B (me) Specifični agensi koji vezuju humani angiopoetin-2
ATE446313T1 (de) Muteine von tränen-lipocalin
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
IS5543A (is) Nýr G próteintengdur viðtaki
DE69631544D1 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
ATE388963T1 (de) Homogene herstellungen von il-29
WO2003104282A8 (en) IMMUNOADHESIN COMPRISING A GLYCOPROTEIN VI DOMAIN
BG104267A (en) Aminoterminally incised rantes as haemokin antagonists
DK0479912T3 (da) Fremgangsmåde til hæmning af N-endereglens forløb i levende celler
ATE529445T1 (de) Biokinetik zur schnellen beseitigung von polypeptiden
ATE367438T1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
DK1098972T3 (da) Protein med lighed med neuroendokrinspecifikt protein samt cDNA kodende derfor
WO2003012053A8 (en) Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis
SE9803962D0 (sv) Nucleic acid encoding a nervous tissue sodium channel
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
ATE427355T1 (de) Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna
IL175019A0 (en) Cxcl8 antagonists, their preparation and use
TIMPL et al. Disulfide-linked cyanogen bromide peptides of bovine fibrinogen. III. Isolation and identification by sequence analysis of the chain constituents in peptides F-CB2, F-CB4 and F-CB5
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto
ATE438660T1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1448772

Country of ref document: EP

REN Ceased due to non-payment of the annual fee